Upgrade to SI Premium - Free Trial

Ionis Pharmaceuticals (IONS) PT Lowered to $38 at Stifel

February 19, 2025 2:52 PM
Stifel analyst Paul Matteis lowered the price target on Ionis Pharmaceuticals (NASDAQ: IONS) to $38.00 (from $45.00) while maintaining a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change

Next Articles